Mack Mabry
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
-
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 3
- Cell death mechanisms and regulation 3
- Retinoids in leukemia and cellular processes 3
- Oncology 13
- Cancer-related Molecular Pathways 5
- Lung Cancer Research Studies 4
- Co-authors
- Barry D. Nelkin (7 shared papers)Stephen B. Baylin (3 shared papers)Michael Borges (3 shared papers)Douglas W. Ball (2 shared papers)Helgi J. K. van de Velde (1 shared paper)R. Ilona Linnoila (1 shared paper)Herbert Chen (1 shared paper)Jalaja Potluri (9 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (3 papers)Cancer Research (2 papers)Investigational New Drugs (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Mack Mabry
28 papers receiving 1.7k citations
Mack Mabry's Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 586
- Oncology 454
- Genetics 176
- Molecular Biology 1.0k
- Cancer Research 118
Countries citing papers authored by Mack Mabry
This map shows the geographic impact of Mack Mabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mack Mabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mack Mabry more than expected).
Fields of papers citing papers by Mack Mabry
This network shows the impact of papers produced by Mack Mabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mack Mabry. The network helps show where Mack Mabry may publish in the future.
Co-authors
The 25 scholars most cited alongside Mack Mabry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study Hit paper breakdown → | 2018 | 508 |
| 2 | 1997 | 344 | |
| 3 | 1996 | 139 | |
| 4 | 1996 | 123 | |
| 5 | 1999 | 64 | |
| 6 | 2014 | 61 | |
| 7 | 2015 | 53 | |
| 8 | 2014 | 49 | |
| 9 | 2017 | 49 | |
| 10 | 2014 | 47 | |
| 11 | 1999 | 43 | |
| 12 | 2016 | 38 | |
| 13 | 2016 | 37 | |
| 14 | 1999 | 34 | |
| 15 | 1998 | 27 | |
| 16 | Induction of markers of normal differentiation in human colon carcinoma cells by the v-rasH oncogene. | 1993 | 24 |
| 17 | Expression of prokaryotic HhaI DNA methyltransferase is transforming and lethal to NIH 3T3 cells. | 1996 | 24 |
| 18 | 1985 | 16 | |
| 19 | Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung. | 1985 | 11 |
| 20 | Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer. | 1996 | 9 |
About Mack Mabry
Mack Mabry is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Pathology and Forensic Medicine, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Cancer-related Molecular Pathways (5 papers), Protein Degradation and Inhibitors (4 papers), Lung Cancer Research Studies (4 papers), Ubiquitin and proteasome pathways (3 papers), Cell death mechanisms and regulation (3 papers), Retinoids in leukemia and cellular processes (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (586 citations), Oncology (454 citations), Genetics (176 citations), Molecular Biology (1.0k citations) and Cancer Research (118 citations). Mack Mabry has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Barry D. Nelkin, Stephen B. Baylin, Michael Borges, Douglas W. Ball, Helgi J. K. van de Velde, R. Ilona Linnoila, Herbert Chen, Jalaja Potluri, Martin Dunbar and Brenda Chyla. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Investigational New Drugs and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.